Oncology

This is an English translation of the danish ”Valg af stråledosis” patient decision aid. Concerns patients planned to receive high dose stereotactic body radiation therapy for a tumor In the lung located less than 1 cm from the thoracic wall. The patients will be able to choose either high or lower radiation dose. A lower dose will decrease the risk of side effects, but local tumor control might also be decreased. The Danish patient decision aid is being tested in a local randomized trial, SDM Lung SBRT

Subject area   

Treatment, lung cancer or lung metastasis from another primary cancer

Options

• High dose, 66 Gray in 3 fractions
• Lower dose, 45 Gray in 3 fractions
• No treatment
• High dose, 66 Gray in 3 fractions, pall
• Lover dose, 45 Gray in 3 fractions, pall
• No treatment (pall)

Preparation sheet included 

Yes

Developed by

Department of Oncology, Lillebaelt Hospital in collaboration with CFFB

Responsible for update 

Physician, PhD-student Thomas Leth Fink, Department of Oncology, Lillebaelt Hospital

Version

1.3

Scheduled update

November 2023

Access to DECISION HELPER™

For any further questions, please contact Centre for Shared Decision Making.

Users logged into a regional network can access the draft decision aid (pdf)

Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:  

Six of six qualifying criteria are met

This Patient Decision Aid meets the IPDAS qualifying criteria to be defined as a Patient Decision Aid

Five of Five certifying criteria are met

Certifying criteria lower the risk of making a biased decision

Fourteen of seventeen quality criteria are met 

Quality criteria that strengthen the quality of the Patient Decision Aid

 

Only applicable criteria are included in the assessment